Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. (Q47841051)

6 February 2018

title

Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. (English)

1 reference

6 February 2018

0 references

10

Thomas M Kündig

1 reference

6 February 2018

author name string

Kent A Smith

1

1 reference

6 February 2018

Victor L Tam

2

1 reference

6 February 2018

Raymond M Wong

3

1 reference

6 February 2018

Robb R Pagarigan

4

1 reference

6 February 2018

Brenna L Meisenburg

5

1 reference

6 February 2018

Diljeet K Joea

6

1 reference

6 February 2018

Xiping Liu

7

1 reference

6 February 2018

Christiana Sanders

8

1 reference

6 February 2018

David Diamond

9

1 reference

6 February 2018

Zhiyong Qiu

11

1 reference

6 February 2018

Adrian Bot

12

1 reference

6 February 2018

language of work or name

English

0 references

publication date

24 February 2009

1 reference

6 February 2018

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

6 February 2018

volume

27

1 reference

6 February 2018

issue

19

1 reference

6 February 2018

page(s)

2603-2615

1 reference

6 February 2018

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

1 reference

The promise of cancer vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Cancer immunotherapy: moving beyond current vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Recent developments in therapeutic cancer vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Dendritic cells at a DNA vaccination site express the encoded influenza nucleoprotein and prime MHC class I-restricted cytolytic lymphocytes upon adoptive transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Heterologous protection against influenza by injection of DNA encoding a viral protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Human clinical trials of plasmid DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Intralymphatic immunization enhances DNA vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Adjuvant activity of CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Improved tuberculosis DNA vaccines by formulation in cationic lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Efficient loading of identical viral peptide onto class II molecules by antigenized immunoglobulin and influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Fibroblasts as efficient antigen-presenting cells in lymphoid organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.038

10.1016/J.VACCINE.2009.02.038

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

19428867

1 reference

6 February 2018